デフォルト表紙
市場調査レポート
商品コード
1762365

オンコロジーにおける放射線療法市場、規模、シェア、動向、産業分析レポート:放射線タイプ別、治療別、エンドユーザー別、地域別、2025年~2034年の市場予測

Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region - Market Forecast, 2025-2034


出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
オンコロジーにおける放射線療法市場、規模、シェア、動向、産業分析レポート:放射線タイプ別、治療別、エンドユーザー別、地域別、2025年~2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、オンコロジーにおける放射線療法の世界市場規模は2034年までに154億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

オンコロジーにおける放射線療法市場は、がんの治療と管理を目的とした高エネルギー電離放射線の利用を包含します。この治療法では、周囲の健康な組織や臓器へのダメージを最小限に抑えながら、がん細胞の根絶や増殖の阻害を目的として、悪性腫瘍に放射線を正確に照射します。リニアックによる外部照射療法(EBRT)、体内に放射性線源を設置する体内照射療法(ブラキセラピー)、全身を循環する放射性物質を用いた全身照射療法など、さまざまな放射線源や照射技術が用いられています。放射線腫瘍学分野は、高度な画像診断、治療計画ソフトウェア、専門的な医療知識を統合し、さまざまな腫瘍の種類や病期にわたるがん患者の治療結果を最適化します。

同市場は、世界のがん罹患率の増加や放射線照射技術の継続的な進歩に牽引され、より広範な放射線腫瘍学の展望の中で重要なセグメントとなっています。市場概要では、放射線治療を個々の患者や腫瘍の特徴に合わせて調整する個別化医療の普及などの要因に影響されたダイナミックな環境が明らかにされています。強度変調放射線治療(IMRT)、画像誘導放射線治療(IGRT)、陽子線治療、磁気共鳴誘導放射線治療(MRgRT)などの技術革新は、治療の精度と有効性を高め、市場開拓に拍車をかけています。さらに、新興国におけるヘルスケアインフラの拡大や、低侵襲のがん治療オプションに対する需要の高まりは、がん領域における放射線治療の全体的な市場成長および市場ポテンシャルに大きく寄与しています。

オンコロジーにおける放射線療法市場レポートハイライト

放射線タイプ別では、幅広いがん種に適用可能であること、この技術を備えた治療センターが広く普及していることから、外照射療法が現在、世界で最も高い市場シェアを占めています。その非侵襲的な性質と確立された臨床プロトコールが、放射線療法市場における支配的な地位に貢献しています。

治療別では、強度変調放射線治療(IMRT)が現在最大の市場シェアを占めています。これは主に、ビームの強度を調整しながら腫瘍の形状に合わせて放射線量を正確に調整できる高度な機能が、さまざまながん治療で広く採用され、局所制御を改善する効果が実証されているためです。

エンドユーザー別では、病院・医療研究機関が現在最大の市場シェアを占めています。これは主に、放射線治療が基本的な治療手段である病院が包括的ながん治療サービスを提供していること、また病院が扱う患者数が多いこと、医療研究機関が研究活動を行っていることによる。

地域別では、北米が現在がん領域の放射線療法市場で最大のシェアを占めています。アジア太平洋地域は、予測期間中に腫瘍放射線療法市場で最も高い成長率を示すと予測されています。

がん領域の放射線療法市場に積極的に参入している主要企業のうち、買収されていない企業には、Accuray Incorporated、Elekta AB、Mevion Medical Systems、Siemens Healthineers(Varian Medical Systemsを含む)、IBA Worldwide、ViewRay Technologies Inc、Perspective Therapeutics Inc(旧Isoray Inc)、日立製作所(株式会社日立ハイテクの一部)、住友重機械工業株式会社、Carl Zeiss Meditec AG(Carl Zeiss AGの子会社)などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 腫瘍学における世界の放射線治療市場の洞察

  • 市場スナップショット
  • 腫瘍学市場力学
    • 促進要因と機会
      • 世界のがん発症率の増加が市場需要を牽引
      • 治療効果を高める技術の進歩
    • 抑制要因と課題
      • 放射線機器の高コスト
  • PESTEL分析
  • 腫瘍学市場における放射線治療の応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のオンコロジーにおける放射線療法市場:放射線タイプ別

  • 主な調査結果
  • イントロダクション
  • 外部ビーム照射
  • 内部ビーム照射

第6章 世界のオンコロジーにおける放射線療法市場:治療別

  • 主な調査結果
  • イントロダクション
  • 定位放射線手術(SRS)
  • 画像誘導放射線治療(IGRT)
  • 強度変調放射線治療(IMRT)
  • 体積変調アーク治療(VMAT)
  • 近接放射線療法

第7章 世界のオンコロジーにおける放射線療法市場:エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院および医療調査機関
  • 専門放射線治療センター

第8章 世界のオンコロジーにおける放射線療法市場:地域別

  • 主な調査結果
  • イントロダクション
    • オンコロジーにおける放射線療法市場評価:地域別、2020-2034年
  • 北米
    • 北米:放射線タイプ別、2020~2034年
    • 北米:治療別、2020~2034年
    • 北米:エンドユーザー別、2020~2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州:放射線タイプ別、2020~2034年
    • 欧州:治療別、2020~2034年
    • 欧州:エンドユーザー別、2020~2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域:放射線タイプ別、2020~2034年
    • アジア太平洋地域:治療別、2020~2034年
    • アジア太平洋地域:エンドユーザー別、2020~2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ:放射線タイプ別、2020~2034年
    • 中東・アフリカ:治療別、2020~2034年
    • 中東・アフリカ:エンドユーザー別、2020~2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ:放射線タイプ別、2020~2034年
    • ラテンアメリカ:治療別、2020~2034年
    • ラテンアメリカ:エンドユーザー別、2020~2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Accuray Incorporated
  • Carl Zeiss Meditec AG(a subsidiary of Carl Zeiss AG)
  • Elekta AB
  • Hitachi Ltd(part of Hitachi High-Tech Corporation)
  • IBA Worldwide
  • Mevion Medical Systems
  • Perspective Therapeutics Inc(formerly Isoray Inc)
  • Siemens Healthineers(which includes Varian Medical Systems)
  • Sumitomo Heavy Industries Ltd
  • ViewRay Technologies Inc
図表

List of Tables:

  • Table 1 Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 2 Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 3 Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 4 North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 5 North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 6 North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 9 U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 10 Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 13 Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 15 Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 16 UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 17 UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 18 UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 19 France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 20 France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 21 France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 22 Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 24 Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 25 Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 28 Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 30 Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 34 Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 36 Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 43 China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 44 China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 45 China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 46 India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 47 India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 48 India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 52 Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 54 Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 60 South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 61 Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 63 Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 73 UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 75 UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 76 Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 78 Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 81 South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 90 Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 93 Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 96 Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Radiation Therapy in the Oncology Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Radiation Type
  • Figure 7. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Radiation Therapy in the Oncology Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End-User
  • Figure 11. Global Radiation Therapy in the Oncology Market, by End-User, 2024 & 2034 (USD Billion)
目次
Product Code: PM5746

The global Radiation therapy in the oncology market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Radiation Therapy in the Oncology Market Size, Share, Trends, Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), Therapy, End-User, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Radiation therapy in the oncology market encompasses the utilization of high-energy ionizing radiation to treat and manage cancer. This therapeutic modality involves precisely delivering radiation to malignant tumors, aiming to eradicate cancerous cells or impede their growth while minimizing damage to surrounding healthy tissues and organs. Various radiation sources and delivery techniques are employed, including external beam radiation therapy (EBRT) using linear accelerators, internal radiation therapy (brachytherapy) involving the placement of radioactive sources within the body, and systemic radiation therapy using radioactive substances that circulate throughout the body. The radiation oncology field integrates sophisticated imaging, treatment planning software, and specialized medical expertise to optimize treatment outcomes for cancer patients across diverse tumor types and stages.

The market is a critical segment within the broader radiation oncology landscape, driven by the increasing global incidence of cancer and continuous advancements in radiation delivery technologies. The market overview reveals a dynamic environment influenced by factors such as the growing adoption of personalized medicine, which tailors radiation treatments to individual patient and tumor characteristics. Technological innovations, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy, and magnetic resonance-guided radiation therapy (MRgRT), are enhancing treatment precision and efficacy, thereby fueling market development. Furthermore, the expanding healthcare infrastructure in emerging economies and the rising demand for minimally invasive cancer treatment options contribute significantly to the overall market growth and market potential of radiation therapy in oncology.

Radiation Therapy in the Oncology Market Report Highlights:

By radiation type, the external beam radiation segment currently holds the highest market share globally due to its broad applicability across a wide range of cancer types and the widespread availability of treatment centers equipped with this technology. Its non-invasive nature and established clinical protocols contribute to its dominant position in the radiation therapy market.

By therapy, intensity-modulated radiation therapy (IMRT) presently commands the largest market share. This is primarily because of its advanced capability to precisely conform the radiation dose to the tumor's shape while modulating the beam's intensity, leading to widespread adoption across various cancer treatments and its proven efficacy in improving local control.

By end-user, the hospitals & medical research institutes segment currently accounts for the largest market share. This is mainly due to the comprehensive cancer care services offered by hospitals, where radiation therapy is a fundamental treatment modality, along with the significant patient volumes they handle and the research activities undertaken by medical research institutes.

By region, North America currently holds the largest market share in the radiation therapy in the oncology market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the radiation therapy in the oncology market over the forecast period.

The major players actively involved in the radiation therapy in the oncology market, who have not been acquired, include Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, and Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG).

Polaris Market Research has segmented the Radiation Therapy in the Oncology market report based on radiation type, therapy, end-user, and region:

By Radiation Type Outlook (Revenue - USD Billion, 2020-2034)

External Beam Radiation

Internal Beam Radiation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Stereotactic Radiosurgery (SRS)

Image-Guided Radiation Therapy (IGRT)

Intensity-Modulated Radiation Therapy (IMRT)

Volumetric-Modulated Arc Therapy (VMAT)

Brachytherapy

By End-User Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Medical Research Institutes

Specialized Radiotherapy Centers

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Radiation Therapy in the Oncology Market Insights

  • 4.1. Radiation Therapy in the Oncology Market - Market Snapshot
  • 4.2. Radiation Therapy in the Oncology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Global Cancer Incidence Driving Market Demand
      • 4.2.1.2. Technological Advancements Enhancing Treatment Efficacy
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of radiation equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Radiation Therapy in the Oncology Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Radiation Therapy in the Oncology Market, by Radiation Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • 5.3. External Beam Radiation
    • 5.3.1. Global Radiation Therapy in the Oncology Market, by External Beam Radiation, by Region, 2020-2034 (USD Billion)
  • 5.4. Internal Beam Radiation
    • 5.4.1. Global Radiation Therapy in the Oncology Market, by Internal Beam Radiation, by Region, 2020-2034 (USD Billion)

6. Global Radiation Therapy in the Oncology Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • 6.3. Stereotactic Radiosurgery (SRS)
    • 6.3.1. Global Radiation Therapy in the Oncology Market, by Stereotactic Radiosurgery (SRS), by Region, 2020-2034 (USD Billion)
  • 6.4. Image-Guided Radiation Therapy (IGRT)
    • 6.4.1. Global Radiation Therapy in the Oncology Market, by Image-Guided Radiation Therapy (IGRT), by Region, 2020-2034 (USD Billion)
  • 6.5. Intensity-Modulated Radiation Therapy (IMRT)
    • 6.5.1. Global Radiation Therapy in the Oncology Market, by Intensity-Modulated Radiation Therapy (IMRT), by Region, 2020-2034 (USD Billion)
  • 6.6. Volumetric-Modulated Arc Therapy (VMAT)
    • 6.6.1. Global Radiation Therapy in the Oncology Market, by Volumetric-Modulated Arc Therapy (VMAT), by Region, 2020-2034 (USD Billion)
  • 6.7. Brachytherapy
    • 6.7.1. Global Radiation Therapy in the Oncology Market, by Brachytherapy, by Region, 2020-2034 (USD Billion)

7. Global Radiation Therapy in the Oncology Market, by End-User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Medical Research Institutes
    • 7.3.1. Global Radiation Therapy in the Oncology Market, by Hospitals & Medical Research Institutes, by Region, 2020-2034 (USD Billion)
  • 7.4. Specialized Radiotherapy Centers
    • 7.4.1. Global Radiation Therapy in the Oncology Market, by Specialized Radiotherapy Centers, by Region, 2020-2034 (USD Billion)

8. Global Radiation Therapy in the Oncology Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Radiation Therapy in the Oncology Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Radiation Therapy in the Oncology Market - North America
    • 8.3.1. North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.3.3. North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.3.4. Radiation Therapy in the Oncology Market - U.S.
      • 8.3.4.1. U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.3.5. Radiation Therapy in the Oncology Market - Canada
      • 8.3.5.1. Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.4. Radiation Therapy in the Oncology Market - Europe
    • 8.4.1. Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.4. Radiation Therapy in the Oncology Market - UK
      • 8.4.4.1. UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.5. Radiation Therapy in the Oncology Market - France
      • 8.4.5.1. France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.6. Radiation Therapy in the Oncology Market - Germany
      • 8.4.6.1. Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.7. Radiation Therapy in the Oncology Market - Italy
      • 8.4.7.1. Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.8. Radiation Therapy in the Oncology Market - Spain
      • 8.4.8.1. Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.9. Radiation Therapy in the Oncology Market - Netherlands
      • 8.4.9.1. Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.10. Radiation Therapy in the Oncology Market - Russia
      • 8.4.10.1. Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.11. Radiation Therapy in the Oncology Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.5. Radiation Therapy in the Oncology Market - Asia Pacific
    • 8.5.1. Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.4. Radiation Therapy in the Oncology Market - China
      • 8.5.4.1. China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.5. Radiation Therapy in the Oncology Market - India
      • 8.5.5.1. India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.6. Radiation Therapy in the Oncology Market - Malaysia
      • 8.5.6.1. Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.7. Radiation Therapy in the Oncology Market - Japan
      • 8.5.7.1. Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.8. Radiation Therapy in the Oncology Market - Indonesia
      • 8.5.8.1. Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.9. Radiation Therapy in the Oncology Market - South Korea
      • 8.5.9.1. South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.10. Radiation Therapy in the Oncology Market - Australia
      • 8.5.10.1. Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.11. Radiation Therapy in the Oncology Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.6. Radiation Therapy in the Oncology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.4. Radiation Therapy in the Oncology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.5. Radiation Therapy in the Oncology Market - UAE
      • 8.6.5.1. UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.6. Radiation Therapy in the Oncology Market - Israel
      • 8.6.6.1. Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.7. Radiation Therapy in the Oncology Market - South Africa
      • 8.6.7.1. South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.8. Radiation Therapy in the Oncology Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.7. Radiation Therapy in the Oncology Market - Latin America
    • 8.7.1. Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.4. Radiation Therapy in the Oncology Market - Mexico
      • 8.7.4.1. Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.5. Radiation Therapy in the Oncology Market - Brazil
      • 8.7.5.1. Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.6. Radiation Therapy in the Oncology Market - Argentina
      • 8.7.6.1. Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.7. Radiation Therapy in the Oncology Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Accuray Incorporated
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Elekta AB
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Hitachi Ltd (part of Hitachi High-Tech Corporation)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. IBA Worldwide
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mevion Medical Systems
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Perspective Therapeutics Inc (formerly Isoray Inc)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Siemens Healthineers (which includes Varian Medical Systems)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sumitomo Heavy Industries Ltd
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ViewRay Technologies Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development